Manganese Imbalance
Manganese (Mn) is an essential transition-metal trace element involved in many biochemical pathways in the epidermis and dermis. In the body it exists mainly in two biological oxidation states: Mn²⁺ (manganous) and Mn³⁺ (manganic). Although only tiny amounts are needed — total body stores are about 10–20 mg — manganese is an essential cofactor that governs the activity of three key enzyme groups in skin structure and function:
- Manganese superoxide dismutase (Mn-SOD / SOD2): a specialized antioxidant enzyme in the mitochondrial matrix that acts as a shield for mitochondrial DNA and fibroblast membranes against UV light and free radicals.
- Prolidase (peptidase D / PEPD): an Mn²⁺-dependent metalloenzyme that hydrolyzes imidodipeptides to release free proline and hydroxyproline — an irreplaceable recycled supply of raw material for collagen synthesis.
- Glycosyltransferases: Golgi enzymes that need Mn²⁺ to build glycosaminoglycans (GAGs) such as hyaluronic acid and chondroitin sulfate, which keep the dermal extracellular matrix hydrated and full.
When manganese balance is disturbed, there are clear clinical consequences either way: deficiency undermines collagen renewal and mitochondrial function, while excess or poisoning (manganism) causes oxidative stress and altered neuro-cutaneous function.
At Haute-Derma, we use advanced trace-element testing by inductively coupled plasma mass spectrometry (ICP-MS) and new-generation Mn-SOD mimetics in our protocols for reversing dermal aging and restoring skin after injury.
Pathophysiology and Molecular Mechanisms in the Skin
Mn-SOD (SOD2) and Protection of Dermal Fibroblast Mitochondria
- Free Radical Removal in the Mitochondrial Matrix:
- Mitochondria are the power plants of keratinocytes and fibroblasts, but they are also where more than 90% of superoxide radicals are generated, via the electron transport chain.
- Mn-SOD carries an Mn³⁺/Mn²⁺ ion at its active site and rapidly catalyzes the dismutation of toxic superoxide into hydrogen peroxide.
- Manganese deficiency switches off SOD2, so superoxide (O₂⁻) builds up inside mitochondria. This damages mitochondrial DNA (mtDNA), opens the mitochondrial permeability transition (mPT) pore, releases cytochrome c into the cytoplasm and pushes fibroblasts into programmed cell death (apoptosis), causing a rapid loss of dermal volume.
Prolidase (PEPD) and the Collagen Recycling Pathway
- Hydrolysis of Imidodipeptide Bonds:
- Collagen makes up 80% of the dry weight of the skin and is rich in repeating glycine-proline-hydroxyproline sequences. When old collagen is broken down by matrix metalloproteinases (MMPs), it leaves short peptides ending in proline or hydroxyproline, known as imidodipeptides (e.g., X-Pro or X-Hyp).
- Prolidase is the only enzyme in the body that can cleave this bond and free the proline. To take on its active shape, it must bind two Mn²⁺ ions.
- Manganese deficiency shuts down prolidase activity → proline stays locked in dipeptides that cannot be reused → fibroblasts run out of building blocks for new procollagen → the skin thins, wounds heal slowly and depressed, contracted scars form.
Glycosaminoglycan (GAG) Synthesis and the Epidermal Barrier: Mn²⁺ is a cofactor for galactosyltransferase and xylosyltransferase. Without enough Mn²⁺, production of chondroitin sulfate and heparan sulfate falls, the extracellular matrix loses its ability to hold water, and the skin becomes dry, rough and loses its natural plumpness and glow.
Clinical Signs of Manganese Imbalance
Manganese Deficiency
Causes include long-term intravenous nutrition without trace-element supplements, malabsorption syndromes, liver and biliary disease, or inherited prolidase deficiency.
- Impaired Wound Healing and Dermal Atrophy:
- Surgical wounds, abrasions and cosmetic procedure sites close slowly; the scar tissue that forms is weak, may break down again or turn into a depressed scar.
- Skin on the face and forearms becomes thin and atrophic, with a network of fine lines (micro-wrinkling) as collagen renewal stalls.
- Erythematous Scaling Dermatitis: Poorly defined red patches with fine scale on the face, neck and skin folds, along with generalized xerosis.
- Hair and Nail Changes: Slow hair growth, with thin, brittle, lighter hair (turning reddish or straw-colored through an indirect effect on pigment production); thin, soft nails that split into layers (onychodystrophy).
- Inherited Prolidase Deficiency Syndrome: The extreme end of manganese/prolidase deficiency, with chronic, hard-to-heal leg ulcers, spider-like telangiectasias, purpura and a prematurely aged appearance.
Manganese Excess and Toxicity
This usually results from inhaling manganese dust at work (metallurgy, welding, battery manufacturing) or from drinking manganese-contaminated groundwater over a long period.
- Hyperpigmentation and Inflammatory Keratosis: Excess free manganese ions (Mn²⁺/Mn³⁺) drive Fenton-type oxidation reactions that injure epidermal keratinocytes. The skin develops patchy dark gray or brown hyperpigmentation with keratotic papules and superficial pustules.
- Neurologically Driven Sweat and Sebum Disorders (Seborrhea and Hyperhidrosis): Systemic manganese poisoning damages the basal ganglia (manganism, a Parkinson-like syndrome). This disrupts the autonomic control of the skin, causing severe facial seborrhea with a greasy, mask-like face, together with localized hyperhidrosis.
How We Diagnose It at Haute-Derma
Assessing manganese status accurately requires both trace-element measurement and tests of enzyme function:
- Modern Quantitative Tests:
- Serum/plasma manganese (ICP-MS): Measures circulating manganese (reference range: 0.5–1.2 µg/L).
- Serum prolidase activity (SPA): The key biochemical marker of the body's capacity to renew collagen.
- 24-hour urine manganese: Assesses excretion and manganese poisoning (normal value < 2.0 µg/day).
- Hair tissue mineral analysis (HTMA): Reflects chronic manganese accumulation from the environment.
Telling Deficiency and Excess Apart
| Feature | Manganese (Mn) Deficiency | Manganese Excess / Toxicity |
|---|---|---|
| Main molecular mechanism | Reduced Mn-SOD and inactive prolidase | Increased Mn²⁺/Mn³⁺ Fenton reactions and neurotoxicity |
| Typical skin findings | Thin, atrophic skin + slow-healing ulcers/wounds | Gray hyperpigmentation + mask-like seborrhea |
| Hair and nails | Hair turns reddish/straw-colored; soft nails that split | No clear change, or brittle hair |
| Laboratory markers | Low serum Mn, low prolidase activity | Markedly raised 24-hour urine Mn and serum Mn |
Treatment and Uses in Aesthetic Dermatology
Treating Systemic Manganese Deficiency
- Oral Supplements:
- We use manganese gluconate, manganese amino acid chelate or manganese ascorbate at 2–5 mg of elemental manganese per day for 6–8 weeks.
- Note: Do not take manganese together with high doses of iron or phosphorus, as they compete for absorption in the gut through the DMT1 metal transporter.
Managing Manganese Poisoning
- Remove the Source: Stop using the contaminated water supply or move away from the industrial exposure.
- Chelation Therapy: In severe poisoning with neurological and skin involvement, the chelating agent calcium disodium EDTA is used to speed up manganese excretion through the kidneys.
Aesthetic Applications at Haute-Derma
- New-Generation Mn-SOD Mimetics (EUK-134 / Mn-Porphyrin Complexes):
- EUK-134 is a synthetic manganese-containing compound that mimics the activity of two enzymes: superoxide dismutase (SOD) and catalase.
- In advanced anti-aging serums, it neutralizes free radicals right at the skin surface and in the epidermis, helping prevent UV-related post-inflammatory hyperpigmentation (PIH).
- Manganese Tripeptide Complexes for Depressed Scars and Skin Recovery: A solution containing trace manganese plus precursor amino acids (proline, glycine, lysine) is delivered by mesotherapy or by electroporation after fractional CO₂ laser. The aim is to support local prolidase activity, shorten healing time and build a thicker dermal collagen matrix.
